Nationwide Trends in Idiopathic Pericarditis Management and Outcomes in Japan ― A Nationwide JROAD-DPC Analysis ―
Among hospitalized patients with idiopathic pericarditis, prescription rates of medications recommended by European Society of Cardiology guidelines have increased, although the concurrent use of NSAIDs and colchicine remains uncommon; there have been no changes in the incidence of in-hospital death. Prospective studies, including outpatients, are needed to clarify the prognosis and recurrence rate of idiopathic pericarditis.
Authors
- Yu Kataoka (ORCID: https://orcid.org/0000-0001-6307-5593)
- Hirohiko Aikawa
- Yoko Sumita (ORCID: https://orcid.org/0000-0002-1424-145X)
- Kazuhiro Nakao (ORCID: https://orcid.org/0000-0002-9034-3976)
- Fumiyuki Otsuka (ORCID: https://orcid.org/0000-0003-4162-2036)
- Masashi Fujino (ORCID: https://orcid.org/0000-0002-2706-4317)
- Yasuhide Asaumi (ORCID: https://orcid.org/0000-0002-9009-7234)
- Koshiro Kanaoka (ORCID: https://orcid.org/0000-0001-7900-7835)
- Michikazu Nakai (ORCID: https://orcid.org/0000-0003-2240-1510)
- Kensuke Takagi (ORCID: https://orcid.org/0009-0009-9547-2441)
- Teruo Noguchi
- Yoshihiro Miyamoto
- Kenichi Tsujita
- Yoshio Tahara
Institutions
- National Cerebral and Cardiovascular Center (JP)
- Health Information Management (BE)
- University of Miyazaki Hospital (JP)
- Monash University (AU)
- Kumamoto University (JP)
Publication Details
- Journal
- Circulation Journal
- Published
- 2025-03-29
- DOI
- https://doi.org/10.1253/circj.cj-24-0697
- Citations
- 2
- Primary Topic
- Pericarditis and Cardiac Tamponade
- Type
- article
- Field-Weighted Citation Impact
- 2.78
Funders
- Amgen
- Sanofi
- Kowa Company
- National Cerebral and Cardiovascular Center
- Nipro
- Daiichi-Sankyo
- Astellas Pharma